Rothwell, Alexander John — Insider Profile

Insider Profile

Rothwell, Alexander John

🔒 Follow — get an alert on any new filing

$EPRX

Companies Filed At

Open-Market Buys (2yr)

$1.7M

Buy Value (2yr, open-market)

Jun 15, 2026

Most Recent Trade

Cross-Company Track Record

—

Hit Rate · 90d

-23.9%

Median Alpha · 90d

Closed Buys Evaluated

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 4 closed buys with individual return outcomes available on the Research plan.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 15, 2026	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	156,250	$8.45	$1.3M	62
Jun 15, 2026	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	46,500	—	—	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	44,000	$3.00	$132K	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	94,000	$3.00	$282K	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	10,000	$3.00	$30K	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	50,000	$3.00	$150K	62
Jan 23, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	10,000	$3.00	$30K	62
Jan 21, 2026	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	20,000	$11.20	$224K	62
Jan 21, 2026	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	108,375	$11.20	$1.2M	62
Jan 21, 2026	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	21,625	$11.20	$242K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	23,000	$8.63	$198K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	600,000	$8.63	$5.2M	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	23,000	$8.63	$198K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	46,500	$8.63	$401K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	46,500	$8.63	$401K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	600,000	$8.63	$5.2M	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	387,500	$8.00	$3.1M	62

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.